111 – 120 of 179
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
The burden of rheumatoid arthritis and access to treatment: outcome and cost-utility of treatments
(
- Contribution to journal › Article
-
Mark
Collagen type II is recognized by a pathogenic antibody through germline encoded structures
(
- Contribution to journal › Article
-
Mark
Anti-TNF treatment of chronic arthritis in clinical practice. New assessment method and predictors of efficacy and tolerability.
(
- Thesis › Doctoral thesis (compilation)
-
Mark
The burden of rheumatoid arthritis and access to treatment: uptake of new therapies
(
- Contribution to journal › Article
-
Mark
The burden of rheumatoid arthritis and access to treatment: determinants of access
(
- Contribution to journal › Article
- 2007
-
Mark
Cardiovascular risk factors, fitness and physical activity in rheumatic diseases.
(
- Contribution to journal › Scientific review
-
Mark
Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials
(
- Contribution to journal › Article
-
Mark
Cystatin C binds serum amyloid A, downregulating its cytokine-generating properties
(
- Contribution to journal › Article
-
Mark
Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies
(
- Contribution to journal › Article
-
Mark
Trends in medication and health-related quality of life in a population-based rheumatoid arthritis register in Malmo, Sweden
(
- Contribution to journal › Article